Director at Sherwin-Williams (NYSE: SHW) awarded 558 RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Gamgort Robert James reported acquisition or exercise transactions in this Form 4 filing.
Sherwin-Williams director Robert James Gamgort reported receiving a grant of 558 restricted stock units (RSUs) of Common Stock on February 17, 2026 at a reported price of $0 per share under the 2025 Equity and Incentive Compensation Plan. Each RSU represents one share of Sherwin-Williams common stock and will vest in three substantially equal annual installments starting on February 16, 2027. After this grant, Gamgort beneficially owns 1,075 RSUs directly, and separately holds 380.04 deferred stock units indirectly through the 2005 Director Deferred Fee Plan, including units accumulated via dividend reinvestment.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Gamgort Robert James
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 558 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,075 shares (Direct);
Common Stock — 380.04 shares (Indirect, Deferred Fee Plan)
Footnotes (1)
- Grant of restricted stock units ("RSUs"), pursuant to the terms of an RSU agreement under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock. The RSUs vest annually in three substantially equal installments commencing February 16, 2027. These securities consist of 1,075 RSUs. No transaction is being reported on this line. Reported on a previously filed Form 4. These securities consist of deferred stock units, held pursuant to the 2005 Director Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.
FAQ
What insider transaction did SHW director Robert James Gamgort report?
Robert James Gamgort reported an acquisition of 558 restricted stock units of Sherwin-Williams Common Stock. The grant was recorded on February 17, 2026 as an award under the 2025 Equity and Incentive Compensation Plan at a reported price of $0 per share.
How many Sherwin-Williams RSUs does Robert James Gamgort now hold?
Following the reported grant, Robert James Gamgort beneficially owns 1,075 restricted stock units of Sherwin-Williams Common Stock directly. These RSUs are tied to the company’s 2025 Equity and Incentive Compensation Plan and are scheduled to vest over three annual installments beginning February 16, 2027.
When do Robert James Gamgort’s new Sherwin-Williams RSUs start vesting?
The newly granted Sherwin-Williams RSUs to Robert James Gamgort begin vesting on February 16, 2027. They vest annually in three substantially equal installments, meaning the award is spread over three years under the terms of the 2025 Equity and Incentive Compensation Plan.
What is the nature of the indirect Sherwin-Williams holdings reported by Gamgort?
In addition to directly held RSUs, Gamgort reported 380.04 deferred stock units held indirectly under the 2005 Director Deferred Fee Plan. These deferred units include amounts accumulated through the plan’s dividend reinvestment feature, reflecting stock-based fees deferred rather than taken in cash.
Was cash paid for the Sherwin-Williams RSU grant to director Gamgort?
The RSU grant to director Robert James Gamgort was reported at a transaction price of $0 per share. This indicates the award was granted as equity compensation under the 2025 Equity and Incentive Compensation Plan rather than purchased in an open-market cash transaction.
Does the Form 4 show any Sherwin-Williams stock sales by Robert James Gamgort?
The Form 4 reports a grant of 558 RSUs to Robert James Gamgort and updated holdings, but it does not show any sale transaction. One common stock line is described as having no new transaction, referencing a previously filed Form 4 for that position.